Patents Examined by Michele Flood
  • Patent number: 9233066
    Abstract: Formulations with antibacterial and biofilm removing actions in which the formulations have at least one plant oil from a plant from the genus Protium, Guatteria, Cyperus in a suitable vehicle.
    Type: Grant
    Filed: December 28, 2007
    Date of Patent: January 12, 2016
    Assignee: Instituto Nacional de Pesquisa da Amazonia—INPA
    Inventors: Renilto Frota Correa, Janaína Paolucci Sales, Jaqueline De Araújo Bezerra, Diego De Moura Rabelo, Luiz Antonio De Oliveira, Maria L{dot over (u)}cia Belém Pinheiro, Silo Soares Da Silva, Spartaco Astolfi Filho
  • Patent number: 9222079
    Abstract: A method of increasing expression of the aromatase gene by treating a cell population with an effective amount of an aromatase activator containing an extract of Iris florentina, where the effective amount ranges from 0.0001 to 1% by weight based on the total weight of the aromatase activator on a dry basis.
    Type: Grant
    Filed: December 16, 2010
    Date of Patent: December 29, 2015
    Assignee: KAO CORPORATION
    Inventors: Shingo Kakuo, Shigeru Moriwaki, Atsushi Ohuchi, Hiroshi Kusuoku
  • Patent number: 9180154
    Abstract: Magnoliidae compounds are made by obtaining parts of Magnoliidae plants. The parts of the Magnoliidae plants are mixed with alcohol and water. The mixture of the parts of the Magnoliidae plants, alcohol and water is heated and the parts of the Magnoliidae plants are removed so that a liquid mixture remains. The liquid mixture is drying to form a solid composition. Alcohol and water are added to the solid composition to reconstitute the solid composition into a liquid composition. The liquid composition is heated to form solid matter. The solid matter is dried to obtain a purified composition of the Magnoliidae compounds. A dose of Magnoliidae compounds promotes weight loss and can be administered in liquid form, sublingually, intravenously, in a pharmaceutically acceptable carrier, in combination with a metabolite detoxification agent, in combination with a nutritional or dietary supplement, or in chewing gum.
    Type: Grant
    Filed: November 5, 2009
    Date of Patent: November 10, 2015
    Assignee: Arizona Health Consulting Group, LLC
    Inventors: Yibing Wang, Peter J. Reilly
  • Patent number: 9176146
    Abstract: Disclosed are compositions that inhibit brain blood vessel leakage, compositions for treating autism spectrum disorders, methods of treating autism spectrum disorders, and methods of screening for an autism spectrum disorder.
    Type: Grant
    Filed: August 3, 2009
    Date of Patent: November 3, 2015
    Assignee: Theta Biomedical Consulting & Development Co., Inc.
    Inventor: Theoharis C. Theoharides
  • Patent number: 9125879
    Abstract: The present invention relates to a composition containing a quinoa grain extract, said extract being a peptidic and osidic extract or a lipidic extract of quinoa grain, said lipid quinoa extract being itself chosen from a group comprising an oil concentrated into its non saponificable fraction, a non saponificable, or a refined oil. The invention also relates to methods for preparing these different extracts and to dermatological or neutraceutic applications of these extracts.
    Type: Grant
    Filed: December 28, 2007
    Date of Patent: September 8, 2015
    Assignee: LABORATOIRES EXPANSCIENCE
    Inventor: Philippe Msika
  • Patent number: 9102962
    Abstract: A production method effectively increases the amount and yield of mushroom beta-glucan, and widely applied in the fields of food, biotechnology, cultivation and medical development. The cultivating medium contains the nutrition of three natural grains, including brown rice, adlay and oat, to provide a complete physiological environment for the mushrooms to grow well. Experimental results strongly suggest that AMFM treated cell activities are significantly enhanced in comparison with those without AMFM treated.
    Type: Grant
    Filed: December 26, 2007
    Date of Patent: August 11, 2015
    Inventor: Shiu Nan Chen
  • Patent number: 9101657
    Abstract: This invention is intended to further improve the effects of alleviating hangover symptoms with the use of a composition comprising a turmeric extract. In particular, this invention is intended to provide a composition that alleviates specific hangover symptoms, such as heartburn and dull headache. The present inventors found that a composition comprising a turmeric (Curcuma longa) extract and a zedoary (Curcuma zedoaria) extract is capable of effectively suppressing heartburn and dull headache among hangover symptoms. The effects attained with the use of the composition of the present invention are remarkable for a person with low aldehyde dehydrogenase activity.
    Type: Grant
    Filed: September 21, 2010
    Date of Patent: August 11, 2015
    Assignee: HOUSE FOODS CORPORATION
    Inventors: Toshiya Minami, Masayoshi Kushi
  • Patent number: 9050275
    Abstract: Disclosed are methods of screening for an autism spectrum disorder, compositions that inhibit the release of molecules that disrupt the blood-brain barrier, compositions for treating autism spectrum disorders, and methods of treating autism spectrum disorders.
    Type: Grant
    Filed: January 19, 2011
    Date of Patent: June 9, 2015
    Assignee: Theta Biomedical Consulting & Development Co., Inc.
    Inventor: Theoharis C. Theoharides
  • Patent number: 8961993
    Abstract: Provided is a method for improving day photopic vision and/or cone-derived visual field and visual function in a subject suffering from a retinal disease or trauma including administering to the subject a pharmaceutically effective amount of crude Dunaliella powder. Also provided is a method for improving night vision and/or rod derived visual field in a subject suffering from a retinal disease including administering to the subject a pharmaceutically effective amount of crude Dunaliella powder. A pharmaceutical composition for improving day vision and/or visual field in a subject suffering from a retinal disease including crude Dunaliella powder is also provided.
    Type: Grant
    Filed: July 18, 2013
    Date of Patent: February 24, 2015
    Assignees: Nikken Sohonsha Corporation, Tel Hashomer Medical Research Infrastructure and Services Ltd.
    Inventors: Michael Belkin, Aviv Shaish, Dror Harats, Ygal Rotenstreich
  • Patent number: 8883226
    Abstract: A pharmaceutical composition for the prevention and treatment of inflammatory disease or asthma comprising the extract of Decaspermum fruticosum as an active ingredient. The extract of Decaspermum fruticosum of the present invention inhibited the increase of eosinophils in bronchoalveolar lavage fluid of the ovalbumin induced asthma animal model, had the activity of inhibiting the secretions of immunoglobulin and chemokine (Eotaxin) in bronchoalveolar lavage fluid and blood, and inhibited the secretions of NO and TNF-? in macrophages. Therefore, the extract of Decaspermum fruticosum of the present invention can be effectively used as an active ingredient of a pharmaceutical composition for the prevention and treatment of inflammatory disease or asthma, and of a health functional food for the prevention and improvement of inflammatory disease or asthma.
    Type: Grant
    Filed: February 7, 2012
    Date of Patent: November 11, 2014
    Assignee: Korea Institute of Oriental Medicine
    Inventors: Sei Ryang Oh, Kyung Seop Ahn, Ok-Kyoung Kwon, Hyeong Kyu Lee, Joongku Lee, Hyouk Joung, Mee-Young Lee, Hwa-Young Son, Kyoung-youl Lee, Sang Woo Lee, Hang Jin, Wan Yi Li
  • Patent number: 8679553
    Abstract: An herbal composition for providing a beneficial effect to the respiratory tract. The composition includes Thyme Leaf, Wild Cherry Bark, Cocoa Extract, Mullein Leaf Extract, and Boswellia Serrata. In particular, the composition may prevent or treat cough, specifically caused by exposure to smoke. Also described are methods of using the herbal composition.
    Type: Grant
    Filed: December 26, 2012
    Date of Patent: March 25, 2014
    Assignee: Aadvantics Pharmaceuticals, Inc.
    Inventors: Brian M. Levine, William E. Berger
  • Patent number: 8580321
    Abstract: The use of flagellin and flagellin related polypeptides for reducing cancer treatment side effects in mammals is described.
    Type: Grant
    Filed: February 11, 2009
    Date of Patent: November 12, 2013
    Assignee: The Cleveland Clinic Foundation
    Inventors: Andrei V. Gudkov, Vadim Krivokrysenko, Lyudmila Burdelya
  • Patent number: 8501162
    Abstract: A composition for the prevention or inhibition of free radical-induced effect on the skin and/or hair comprises at least three antioxidant agents selected from the group consisting of ginkgo extract, emblica extract, dimethylmethoxy chromanol, pine bark extract, and rosemary extract.
    Type: Grant
    Filed: September 29, 2008
    Date of Patent: August 6, 2013
    Assignee: The Boots Company PLC
    Inventors: Stephen Peter Barton, Mark Johnson, Paul James Tomlinson
  • Patent number: 8491946
    Abstract: An elastase inhibitor that contains as active ingredients thereof raspberry extract and hydroxyproline, and optionally further contains yeast extract.
    Type: Grant
    Filed: August 6, 2010
    Date of Patent: July 23, 2013
    Assignee: Shiseido Company, Ltd.
    Inventor: Masato Iino
  • Patent number: 8486462
    Abstract: 3-O-?-D-Glucopyranosyl-4-methylergost-7-en-3-ol or a composition containing 0.001% by mass or more of the aforementioned compound, which is an extract of a plant of the family Liliaceae containing the compound or a fraction thereof, is used as an active ingredient of a hyperglycemia improving agent.
    Type: Grant
    Filed: July 25, 2008
    Date of Patent: July 16, 2013
    Assignee: Morinaga Milk Industry Co., Ltd.
    Inventors: Ryuuichi Higuchi, Masanori Inagaki, Hirotoshi Hayasawa, Muneo Yamada, Miyuki Tanaka, Eriko Misawa, Noriko Wakimoto, Yousuke Itou
  • Patent number: 8470378
    Abstract: The present invention relates to an antiviral composition comprising an Alnus japonica extract, more specifically, relates to a method for preparing high activated anti-influenza viral composition, which comprises an extract of the bark or stem of Alnus japonica, and an anti-influenza viral composition comprising the extract. An extract of the bark or stem of Alnus japonica according to the present invention has low toxicity to normal cells, while having an excellent antiviral effect even when administered at low concentration and thus the composition comprising the Alnus japonica extract can be used effectively in preventing and treating influenza viral infection.
    Type: Grant
    Filed: March 7, 2012
    Date of Patent: June 25, 2013
    Assignee: RNL Bio Co., Ltd
    Inventors: Jeong Chan Ra, Hyuk Joon Kwon, Byeung Gie Kim, Seok Hyon You
  • Patent number: 8455017
    Abstract: An active substance of medication or health product for hyperlipidemia and hypercholesterolemia comprises djulis, and which can effectively inhibit the absorption of cholesterol, advance the metabolism of cholesterol, promote the anti-oxidation and decrease the accumulation of oxidized low-density lipoprotein-cholesterol in vessel walls of organisms.
    Type: Grant
    Filed: April 15, 2011
    Date of Patent: June 4, 2013
    Assignee: National Pingtung University of Science & Technology
    Inventors: Pi-Jen Tsai, Hso-Chi Chaung
  • Patent number: 8455020
    Abstract: A method of producing a product to correct hypercholesterolemia including pulping fruits of Emblica officinalis with demineralized water to create a slurry. The slurry is treated with pectinase. The pectinase-treated slurry is filtered to create a solution. The solution is concentrated to create a product. A product having an extract of Emblica officinalis for prophylactic and for therapeutic treatment of coronary diseases, atherosclerosis, hypothyroidism and hyperthyroidism.
    Type: Grant
    Filed: January 24, 2012
    Date of Patent: June 4, 2013
    Assignee: Arjuna Natural Extracts, Ltd
    Inventor: Benny Antony
  • Patent number: 8420834
    Abstract: Disclosed is a process for manufacturing crude Artemisinin comprising the extraction of Artemisia annua from plant material with carbon dioxide or water in a critical physical state such that after extraction, the solvent evaporates completely from the resulting extract.
    Type: Grant
    Filed: September 25, 2008
    Date of Patent: April 16, 2013
    Assignee: Lachifarma S.r.l. Laboratorio Chimico Farmaceutico Salentino
    Inventors: Felicia Cisale, Azzurra Villanova, Luciano Villanova
  • Patent number: 8420132
    Abstract: Disclosed herein are novel dietary supplement compositions comprising enriched 3-O-acetyl-11-keto-?-boswellic acid and enriched demethylated curcuminoids, wherein the composition exhibits anti-inflammatory, antiulcerogenic and anti-oxidant activities. Also disclosed are novel compositions comprising enriched 3-O-acetyl-11-keto-?-boswellic acid, enriched demethylated curcuminoids that have a synergistic effect on specific inhibition of—COX-2 and 5-LOX activity and optionally containing glucosamine, resveratrol, garlic extract, chondroitin, methlysulphonymethane, bromelain, serratiopeptidase, quercitine, gallic acid, caffeic acid, green tea extract, aspirin and ibuprofen.
    Type: Grant
    Filed: May 3, 2012
    Date of Patent: April 16, 2013
    Assignee: Laila Impex
    Inventors: Ganga Raju Gokaraju, Rama Raju Gokaraju, Trimurtulu Golakoti, Venkateswarlu Somepalli